Being an THCZ/RMHB investor since late 2014 , every now and
Being an THCZ/RMHB investor since late 2014 , every now and then I like to give my "realism, non fluff" checklist of what I see as RMHB biggest advantages and challenges.
Keep in mind that I am not an optimist, nor a pessimist but I lean towards the side of reality and "say it like I see it" :
The Good:
1- RMHB has successfully made the OTCQB and has goals to get to a larger exchange
2- We have several good to great products in an increasingly growing(energy drinks/water) and baby(hemp) industry's
3-RMHB has been purchased by Ms Li and seems to have access to non dilutive financing.
4-RMHB seems to have huge potential in the China market from Ms Li's contacts
5- We are making inroads to local public awareness - at least on the OTC stock level
6- We are making progress with some national distributors such as 7/11
7-Soon to hit the huge california market with much larger distribution as well as other local areas.
8-aligning with The Native americans for the Eagle spiirt water deal could be a large coup and lead to large water sales within the Native Indian community and elsewhere.
9-Buying that resort in the catskills with a spring might be a monster deal.
10-Overall growing public awareness and acceptance with Hemp and MM could help make RMHB be a leader and "first to market" in several successful product catagories.
11-The Weed ETF could be a large boost to stock price when eventually approved by the SEC (might take awhile)
12- The potential for being acquired in a few years- if things come together as planned- is growing.
The Challenges
1- Eventually will need to Produce and have Sales.
2- see #1
3-The unknowns of Ms Li, , China deals and overall stock purchase deals,Money infusions
3- Timing of next production runs and orders from larger companies and how are they getting financed?
4- Facebook likes for the company FB page have been stuck at 30k for 2 years. Has not caught on yet.
5-Since the stock transfer has been announced last week VNDM(the dilutive market maker) has been continually on the ask holding the share price down (in case anyone wanted to know why we haven't moved too much-that is the reason) and why is VNDM selling shares?
6- though not really a MJ stock ,we are lumped into it and any national change in MJ policy could affect us
7- Amount of outstanding shares compared to sales.
8-challenges thus far in getting product on shelves with national companies.
9- eventually will need to turn the "if's , mights' and other future looking statements into Sales -see #1
so this is my annual list that is always subject to change and is ever changing.... and of course, is from my viewpoint as I see it.
I have great faith in RMHB and am looking forward to a great future.
Just thought I needed to put this out there as sometimes get too much bashing stuff as well as too much fluff - Lets try to keep it real.
17
Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...
Continue Reading
Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...
Continue Reading
A thermostat war in the bedroom is a lousy reason to buy the wrong mattress. Yet that is the mundane, very real problem Sleep Number is leaning into after Expert Consumers named it a leading 2026 choice for couples seeking personalized sleep comfort. The company’s argument is straightforward: two people sharing a bed should not have to share one firmness setting, or...
Continue Reading
A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...
Continue Reading
Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...
Continue Reading
A language gap rarely makes the loudest noise in an earnings call, yet it can quietly wreck a sales effort, a hiring plan, or a customer relationship. ACTFL's updated 2026 employer study puts some hard edges around that problem: U.S. businesses say multilingual capability is not a nice cultural accessory. It is increasingly part of operating the business. Demand Has Moved...
Continue Reading
A toddler surviving on three bites Tuesday is not a verdict on the family table. That plain idea sits at the center of pediatric expert Kathy Shirazi’s guidance on childhood nutrition, and frankly, it deserves more oxygen than another impossible-looking lunchbox photo. In the HelloNation article released November 20, 2026, Shirazi, MD, MPH, FAAP, urges parents to judge...
Continue Reading
A crowded family attraction map is a nice problem for a Texas city to have, and North Richland Hills is trying to turn that pile of assets into a cleaner regional tourism machine. On Nov. 20, 2026, the city introduced “The Place You Never Outgrow,” its first destination-marketing campaign, built with Flat Five Marketing. This is not a stock story in the usual...
Continue Reading
A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...
Continue Reading
Thirty Minutes Can Still Matter A half-hour fireside chat is not a quarterly earnings call, and anybody treating it like one is setting themselves up for disappointment. Still, S&P Global CEO Martina Cheung appearing at the UBS Global Technology and AI Conference on December 2 deserves a spot on the calendar for owners of NYSE:SPGI. This is a company sitting in the middle...
Continue Reading
Top 5 Most Recently Viewed Articles
Specialty1 Partners Fuels Growth with Innovative Model Specialty1 Partners (S1P) has emerged as a leader in the specialty dental partnership sector, focusing on aiding Endodontists, Periodontists, and Oral Surgeons in elevating their practices. Their innovative joint venture model is increasingly attracting dental specialists eager to transition from associates to...
Continue Reading
Union Pacific's Ambitious Merger Talks Union Pacific Corp. (NYSE: UNP) is reportedly engaged in preliminary discussions to acquire Norfolk Southern Corp. (NYSE: NSC), marking a prospective mega-merger in the railroad industry. While details are still emerging, the implications of such a merger could significantly reshape the freight transport landscape across the United...
Continue Reading
Overview of Financial Achievements Great Elm Capital Corp. (NASDAQ: GECC) has recently released its financial performance report for the second quarter, demonstrating remarkable growth and a prosperous quarter for the company. This update is essential for investors and stakeholders keen on understanding the company's current financial health and future prospects. Record...
Continue Reading
Scandinavian Tobacco Group A/S launched a significant share buy-back program back in November, worth up to DKK 850 million. The move aimed at adjusting the company's capital structure and meeting obligations tied to its share-based incentive programs. This isn’t just a random act; it’s a strategic ploy in a competitive market that’s meant to bolster their stock...
Continue Reading
Exciting Developments in Telitacicept Phase III Trial Results The Phase III clinical trial results for Telitacicept are sparking significant interest, particularly within the realm of Sjögren's Syndrome. This autoimmune condition can severely affect patients' quality of life due to symptoms like dry mouth and dry eyes, among others. Recently, announcements surrounding...
Continue Reading